This analysis unveiled several promising biomarkers, such as MMP9, PIK3R6, IFNG, and PGF, exhibiting significant associations with overall survival and relapse-free survival in ccRCC patients. The gene discussed is IFNG; the disease is nonpapillary renal cell carcinoma.